Page last updated: 2024-12-10

feruloylputrescine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

feruloylputrescine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5281796
CHEBI ID9299
MeSH IDM0179256

Synonyms (31)

Synonym
nsc602818
nsc-602818
cinnamamide, n-(4-aminobutyl)-4-hydroxy-3-methoxy-
2-propenamide, n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)-
subaphylline
n-feruloylputrescine
4-oxy-3-methoxycinnamylputrescine
n-(4-aminobutyl)-4-hydroxy-3-methoxycinnamamide
feruloylputrescine
501-13-3
(e)-n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide
CHEBI:9299
trans-n-feruloylputrescine
(2e)-n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)-2-propenamide #
SFUVCMKSYKHYLD-FNORWQNLSA-N
(e)-n-(4-aminobutyl)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enamide
2-propenamide, n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)-, (2e)-
J3HM10B75D ,
n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)-2-propenamide
Q27108351
(e)-n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide
unii-j3hm10b75d
91000-11-2
feruloyl putrescine (isomer of 1178)
DTXSID90904144
A871657
AS-75663
CS-0367848
(2e)-n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
2-propenamide, n-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)-, (e)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxycinnamic acidAny member of the class of cinnamic acids carrying one or more hydroxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's2 (28.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.78 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index39.50 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]